Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
Frontiers in Oncology · 20.12.2024 · 14
DOI: 10.3389/fonc.2024.1507335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.12.2024. Verfasst von Xinli Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To comprehensively and noninvasively predict glioma grade, IDH mutation status, 1p/19q codeletion status, and MGMT promoter methylation status using chemical exchange saturation transfer (CEST)-based tumor pH assessment and metabolic profiling.
Methods
We analyzed 128 patients with pathologically confirmed adult diffuse glioma. CEST-derived metrics based on tumor regions were obtained using five-pool Lorentzian analysis and pH_weighted analysis. Histogram features of these metrics were computed to characterize tumor heterogeneity. These features were subsequently employed for glioma grading and molecular genotyping of IDH, 1p/19q and MGMT. Logistic regression analysis was used to predict the grade and IDH genotypes. The diagnostic performance was evaluated using receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis.
Results
The DS, MT and pH_weighted differed significantly between grade II and III, as well as grade III and IV. The amide, NOE, pH_weighted and MTR 3.5 showed significantly differences within IDH genotypes. Regression models achieved the highest AUC for differentiating grade II from III (0.80, 95% CI: 0.64-0.91), grade III from IV (0.83, 95% CI: 0.74-0.90), and IDH mutant from wild status (0.84, 95% CI: 0.77-0.90). MT and pH_weighted metrics were the only indicators for identifying 1p/19q codeletion in grade II and grade III gliomas, respectively. MT 90th percentile (0.87, 95% CI: 0.65-0.98) and pH_weighted 25th percentile (0.83, 95% CI: 0.56-0.97) showed the best performance, respectively. The MTR 3.5 was the only indicator which can distinguish MGMT promoter methylation and unmethylation gliomas, within MTR 3.5 90th percentile performed best (AUC = 0.79, 95% CI: 0.61- 0.91).
Conclusion
CEST-based tumor pH assessment and metabolic profiling demonstrated promising potential for predicting glioma grade, IDH mutation status, 1p/19q codeletion, and MGMT genotype.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Clinical & Technical Solutions, Philips Healthcare, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Lu, J., Liu, X., Sun, P., Qin, Q., Xiang, Z., Cheng, L., Zhang, X., Guo, X., & Wang, J. (2024). Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1507335
Vancouver
Zhang X, Lu J, Liu X, Sun P, Qin Q, Xiang Z, et al. Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1507335
BibTeX
@article{Zhang2024,
author = {Zhang, Xinli and Lu, Jue and Liu, Xiaoming and Sun, Peng and Qin, Qian and Xiang, Zhengdong and Cheng, Lan and Zhang, Xiaoxiao and Guo, Xiaotong and Wang, Jing},
title = {Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1507335}
}
EUVIMED